Prescribing Information | Medication Guide

additional Resources

additional Resources

Help understanding cost support options

Download Icon

Patient Affordability Options for REMICADE®

A summary of some of the cost support options that may be available to you to help make your treatment with REMICADE® more affordable.



Download

SUPPORT FOR YOUR REMICADE® TREATMENT

Download icon

REMICADE® Patient Brochure

This brochure provides information on resources and programs that are available to support your REMICADE® treatment—whether you’re just getting started or looking for options to help you stay on therapy.




Download



Download icon

Discussion Guide

If you are asked to change your medication, this discussion guide provides questions you can ask your doctor to learn more about why you’re being asked to switch and what options are available.




Download

Watch Real People Tell Their Treatment Stories

MODERATELY TO SEVERELY ACTIVE Ulcerative colitis/
MODERATELY TO SEVERELY ACTIVE Crohn's disease treatment
MODERATELY TO SEVERELY ACTIVE Rheumatoid arthritis treatment

Hear from real patients as they talk about the disease, their symptoms, and finding a treatment that was right for them.

MEGAN'S INFUSION EXPERIENCE

Icon Talking

Listen to Megan describe her
experience with intravenous (IV) infusion
treatment with REMICADE®.

BIOSIMILAR FAQs

  • What is a biosimilar?

    A biosimilar is a biological product that is determined to be highly similar to and with no clinically meaningful differences from an existing Food and Drug Administration (FDA)-approved biologic product (also known as a reference product).

    A biologic reference product is the product, already approved by the FDA, against which a biosimilar product is compared.

  • Are biosimilars the same as generic medications?

    Biosimilars are not generics, and there are important differences between the two. Compared to a brand-name drug, a generic drug must have the same active ingredients and must be bioequivalent. By contrast, compared to a biologic reference product, a biosimilar must be highly similar (except for minor differences in clinically inactive components) and must show that there are no clinically meaningful differences in terms of safety and effectiveness.


Cost and coverage glossary


Co-insurance

Your share of the costs of a covered healthcare service, calculated as a percentage (for example, 20%) of the allowed amount for the service. You pay co-insurance once you’ve met your deductible.


Co-payment

A fixed amount (for example, $15) you pay for a covered healthcare service, usually when you receive the service. The amount can vary by the type of covered healthcare service.


Deductible

The amount you owe for healthcare services before your health insurance or plan begins to pay. For example, if your deductible is $1000, your plan won’t pay anything until you’ve met your $1000 deductible for covered healthcare services subject to the deductible. The deductible may not apply to all services.


Out-of-pocket cost

The net amount that it costs you personally, after insurance payments and other forms of support are subtracted from the total cost.


Preauthorization

Sometimes called prior authorization, prior approval, or precertification, this is a decision by your health insurance or plan that a healthcare service, a treatment plan, a prescription drug, or durable medical equipment is medically necessary. Your health insurance or plan may require preauthorization for certain services before you receive them, except in an emergency. Preauthorization isn’t a promise your health insurance or plan will cover the cost.



ISI expand